Suryoday Selling And Marketing Expenses vs Operating Income Analysis

SURYODAY

142.91 2.70 1.85%

Suryoday Small financial indicator trend analysis is much more than just breaking down Suryoday Small Finance prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Suryoday Small Finance is a good investment. Please check the relationship between Suryoday Small Selling And Marketing Expenses and its Operating Income accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Suryoday Small Finance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Selling And Marketing Expenses vs Operating Income

Selling And Marketing Expenses vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Suryoday Small Finance Selling And Marketing Expenses account and Operating Income. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Suryoday Small's Selling And Marketing Expenses and Operating Income is 0.54. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Operating Income in the same time period over historical financial statements of Suryoday Small Finance, assuming nothing else is changed. The correlation between historical values of Suryoday Small's Selling And Marketing Expenses and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of Suryoday Small Finance are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Selling And Marketing Expenses i.e., Suryoday Small's Selling And Marketing Expenses and Operating Income go up and down completely randomly.

Correlation Coefficient

0.54

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Selling And Marketing Expenses

Operating Income

Operating Income is the amount of profit realized from Suryoday Small Finance operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Suryoday Small Finance is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most indicators from Suryoday Small's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Suryoday Small Finance current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Suryoday Small Finance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

At present, Suryoday Small's Selling General Administrative is projected to decrease significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 751.9 M, whereas Issuance Of Capital Stock is forecasted to decline to about 4.8 M.

	2021	2022	2023	2024 (projected)
Gross Profit	6.8B	8.4B	18.1B	19.0B
Total Revenue	6.8B	8.4B	10.2B	10.7B

Gross Profit Total Revenue

Suryoday Small fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Other Current Liab	Other Liab	Net Tangible Assets	Current Deferred Revenue	Accounts Payable	Net Receivables	Inventory
Total Assets		0.86	0.75	0.86	0.96	-0.19	0.92	0.97	0.71	-0.92	0.1	0.82	0.74	0.82	0.97	1.0	0.81	0.65	0.83	-0.88	0.83	0.92	0.44	0.87	0.94	0.3
Short Long Term Debt Total	0.86		0.4	0.94	0.83	0.24	0.74	0.82	0.36	-0.82	0.45	0.53	0.83	0.51	0.87	0.85	0.48	0.69	0.91	-0.65	0.85	0.92	0.05	0.62	0.89	-0.05
Total Current Liabilities	0.75	0.4		0.4	0.74	-0.75	0.79	0.7	1.0	-0.6	-0.58	0.86	0.31	0.99	0.64	0.77	0.96	0.39	0.34	-0.92	0.61	0.53	0.88	0.94	0.67	0.85
Total Stockholder Equity	0.86	0.94	0.4		0.78	0.16	0.79	0.85	0.36	-0.86	0.44	0.62	0.87	0.5	0.91	0.84	0.53	0.66	0.98	-0.6	0.77	0.96	0.12	0.58	0.92	-0.07
Property Plant And Equipment Net	0.96	0.83	0.74	0.78		-0.19	0.81	0.92	0.7	-0.89	0.09	0.71	0.64	0.81	0.91	0.97	0.74	0.54	0.72	-0.88	0.9	0.86	0.38	0.88	0.9	0.31
Net Debt	-0.19	0.24	-0.75	0.16	-0.19		-0.32	-0.21	-0.76	0.09	0.9	-0.58	0.23	-0.66	-0.06	-0.21	-0.69	0.12	0.23	0.49	-0.14	0.02	-0.89	-0.51	-0.17	-0.86
Retained Earnings	0.92	0.74	0.79	0.79	0.81	-0.32		0.91	0.77	-0.8	-0.07	0.93	0.69	0.84	0.88	0.92	0.9	0.7	0.77	-0.85	0.66	0.82	0.58	0.86	0.85	0.43
Cash	0.97	0.82	0.7	0.85	0.92	-0.21	0.91		0.65	-0.91	0.14	0.85	0.72	0.77	0.93	0.97	0.8	0.61	0.81	-0.81	0.8	0.9	0.43	0.8	0.92	0.22
Non Current Assets Total	0.71	0.36	1.0	0.36	0.7	-0.76	0.77	0.65		-0.54	-0.62	0.84	0.28	0.98	0.61	0.73	0.95	0.4	0.3	-0.91	0.58	0.48	0.89	0.92	0.63	0.88
Non Currrent Assets Other	-0.92	-0.82	-0.6	-0.86	-0.89	0.09	-0.8	-0.91	-0.54		-0.23	-0.71	-0.73	-0.66	-0.92	-0.92	-0.68	-0.44	-0.79	0.77	-0.79	-0.93	-0.29	-0.76	-0.91	-0.15
Other Assets	0.1	0.45	-0.58	0.44	0.09	0.9	-0.07	0.14	-0.62	-0.23		-0.31	0.42	-0.47	0.23	0.08	-0.46	0.2	0.49	0.31	0.12	0.33	-0.8	-0.32	0.14	-0.89
Cash And Short Term Investments	0.82	0.53	0.86	0.62	0.71	-0.58	0.93	0.85	0.84	-0.71	-0.31		0.52	0.87	0.74	0.82	0.97	0.54	0.59	-0.81	0.56	0.68	0.77	0.82	0.76	0.56
Common Stock Shares Outstanding	0.74	0.83	0.31	0.87	0.64	0.23	0.69	0.72	0.28	-0.73	0.42	0.52		0.41	0.78	0.72	0.44	0.77	0.93	-0.51	0.58	0.75	0.12	0.49	0.71	-0.07
Non Current Liabilities Total	0.82	0.51	0.99	0.5	0.81	-0.66	0.84	0.77	0.98	-0.66	-0.47	0.87	0.41		0.73	0.84	0.96	0.48	0.45	-0.95	0.68	0.61	0.83	0.96	0.74	0.78
Other Stockholder Equity	0.97	0.87	0.64	0.91	0.91	-0.06	0.88	0.93	0.61	-0.92	0.23	0.74	0.78	0.73		0.96	0.71	0.65	0.88	-0.77	0.78	0.95	0.33	0.77	0.92	0.19
Total Liab	1.0	0.85	0.77	0.84	0.97	-0.21	0.92	0.97	0.73	-0.92	0.08	0.82	0.72	0.84	0.96		0.82	0.63	0.8	-0.89	0.84	0.91	0.46	0.89	0.93	0.33
Total Current Assets	0.81	0.48	0.96	0.53	0.74	-0.69	0.9	0.8	0.95	-0.68	-0.46	0.97	0.44	0.96	0.71	0.82		0.48	0.48	-0.9	0.6	0.62	0.86	0.91	0.74	0.73
Intangible Assets	0.65	0.69	0.39	0.66	0.54	0.12	0.7	0.61	0.4	-0.44	0.2	0.54	0.77	0.48	0.65	0.63	0.48		0.75	-0.48	0.42	0.55	0.25	0.48	0.54	0.11
Common Stock	0.83	0.91	0.34	0.98	0.72	0.23	0.77	0.81	0.3	-0.79	0.49	0.59	0.93	0.45	0.88	0.8	0.48	0.75		-0.54	0.67	0.89	0.09	0.52	0.83	-0.12
Other Current Liab	-0.88	-0.65	-0.92	-0.6	-0.88	0.49	-0.85	-0.81	-0.91	0.77	0.31	-0.81	-0.51	-0.95	-0.77	-0.89	-0.9	-0.48	-0.54		-0.79	-0.7	-0.68	-1.0	-0.81	-0.66
Other Liab	0.83	0.85	0.61	0.77	0.9	-0.14	0.66	0.8	0.58	-0.79	0.12	0.56	0.58	0.68	0.78	0.84	0.6	0.42	0.67	-0.79		0.83	0.27	0.75	0.91	0.23
Net Tangible Assets	0.92	0.92	0.53	0.96	0.86	0.02	0.82	0.9	0.48	-0.93	0.33	0.68	0.75	0.61	0.95	0.91	0.62	0.55	0.89	-0.7	0.83		0.21	0.68	0.97	0.05
Current Deferred Revenue	0.44	0.05	0.88	0.12	0.38	-0.89	0.58	0.43	0.89	-0.29	-0.8	0.77	0.12	0.83	0.33	0.46	0.86	0.25	0.09	-0.68	0.27	0.21		0.7	0.38	0.89
Accounts Payable	0.87	0.62	0.94	0.58	0.88	-0.51	0.86	0.8	0.92	-0.76	-0.32	0.82	0.49	0.96	0.77	0.89	0.91	0.48	0.52	-1.0	0.75	0.68	0.7		0.79	0.68
Net Receivables	0.94	0.89	0.67	0.92	0.9	-0.17	0.85	0.92	0.63	-0.91	0.14	0.76	0.71	0.74	0.92	0.93	0.74	0.54	0.83	-0.81	0.91	0.97	0.38	0.79		0.23
Inventory	0.3	-0.05	0.85	-0.07	0.31	-0.86	0.43	0.22	0.88	-0.15	-0.89	0.56	-0.07	0.78	0.19	0.33	0.73	0.11	-0.12	-0.66	0.23	0.05	0.89	0.68	0.23

Click cells to compare fundamentals

Suryoday Small Account Relationship Matchups

Suryoday Small fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	53.6B	67.1B	81.8B	98.6B	123.8B	130.0B
Short Long Term Debt Total	12.2B	16.9B	18.4B	27.7B	24.4B	12.5B
Total Current Liabilities	220.3M	184.6M	217.4M	494.5M	16.4B	17.2B
Total Stockholder Equity	10.7B	16.0B	15.1B	15.8B	18.0B	9.1B
Property Plant And Equipment Net	387.3M	432.2M	1.2B	1.6B	1.7B	1.8B
Net Debt	3.8B	11.0B	8.6B	19.3B	(11.8B)	(11.2B)
Retained Earnings	2.0B	2.1B	1.1B	1.5B	3.2B	3.3B
Cash	8.4B	5.9B	9.7B	8.3B	11.8B	12.4B
Non Current Assets Total	387.3M	432.2M	1.2B	1.6B	136.2B	143.0B
Non Currrent Assets Other	(8.1B)	(18.7B)	(20.6B)	(25.7B)	(27.7B)	(26.3B)
Other Assets	45.4B	61.7B	76.9B	96.4B	(34.8B)	(33.1B)
Cash And Short Term Investments	7.8B	5.0B	3.8B	566.5M	11.8B	12.4B
Common Stock Shares Outstanding	83.6M	90.3M	106.1M	106.2M	107.0M	79.6M
Liabilities And Stockholders Equity	53.6B	67.1B	81.8B	98.6B	123.8B	130.0B
Non Current Liabilities Total	7.5B	11.1B	20.3B	19.3B	105.7B	111.0B
Other Stockholder Equity	4.9B	11.9B	11.9B	11.9B	13.8B	14.5B
Total Liab	43.0B	51.2B	66.8B	82.8B	105.7B	111.0B
Total Current Assets	7.8B	5.0B	3.8B	566.5M	22.4B	23.5B
Accumulated Other Comprehensive Income	2.9B	3.0B	2.1B	2.9B	17.0B	17.8B
Common Stock	865.9M	1.1B	1.1B	1.1B	1.1B	775.3M
Other Current Liab	(220.3M)	(184.6M)	(217.4M)	(494.5M)	(859.3M)	(816.3M)
Other Liab	1.6B	1.5B	2.2B	2.7B	3.1B	1.9B
Net Tangible Assets	10.7B	16.0B	15.1B	15.8B	18.2B	13.1B
Current Deferred Revenue	(5.2B)	(5.9B)	(5.3B)	(8.1B)	(859.3M)	(902.3M)
Accounts Payable	220.3M	184.6M	217.4M	494.5M	859.3M	902.3M
Net Receivables	567.0M	730.2M	786.3M	820.3M	1.2B	757.9M
Inventory	(9.5B)	(7.4B)	(11.3B)	(10.1B)	10.6B	11.1B
Other Current Assets	8.9B	6.7B	10.6B	9.3B	11.8B	8.3B
Short Term Debt	5.4B	6.1B	5.5B	8.6B	14.1B	7.8B
Property Plant Equipment	387.3M	432.2M	1.2B	1.6B	1.9B	2.0B
Net Invested Capital	22.8B	32.9B	40.6B	43.5B	42.5B	37.1B
Long Term Investments	8.1B	18.7B	20.6B	25.7B	26.0B	19.4B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Other Information on Investing in Suryoday Stock

Balance Sheet is a snapshot of the financial position of Suryoday Small Finance at a specified time, usually calculated after every quarter, six months, or one year. Suryoday Small Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Suryoday Small and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Suryoday currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Suryoday Selling And Marketing Expenses vs Operating Income Analysis

Selling And Marketing Expenses vs Operating Income

Selling And Marketing Expenses vs Operating Income Correlation Analysis

Correlation Coefficient

Selling And Marketing Expenses

Operating Income

Suryoday Small fundamental ratios Correlations

Suryoday Small Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Suryoday Small fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Suryoday Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Current Liabilities
Non Current Liabilities Total	+ 0.99	Total Current Liabilities
Common Stock	+ 0.98	Total Stockholder Equity
Non Current Liabilities Total	+ 0.98	Non Current Assets Total
Cash	+ 0.97	Total Assets

Accounts Payable	- 1.0	Other Current Liab
Other Current Liab	- 0.95	Non Current Liabilities Total
Net Tangible Assets	- 0.93	Non Currrent Assets Other
Total Liab	- 0.92	Non Currrent Assets Other
Other Stockholder Equity	- 0.92	Non Currrent Assets Other
Other Current Liab	- 0.92	Total Current Liabilities